New study on graves and TED treatment - Thyroid UK

Thyroid UK

142,297 members167,662 posts

New study on graves and TED treatment

Juli_a profile image
0 Replies

Hello all, interesting research going on targeting graves thyroid antibodies (trab) and TED

Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease

hra.nhs.uk/planning-and-imp...

[ Admin added paper title to make more obvious what the link copies to. ]

Written by
Juli_a profile image
Juli_a
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Possible immunotherapy treatment for Graves disease

This new paper in Thyroid describes using immunotherapy to alleviate Graves hyperthyroidism. Free...
diogenes profile image
Remembering

Study: ‘Breakthrough’ Drug Reduces Graves’ Eye Disease Symptoms

clinical trial led by the University of Michigan Kellogg Eye Center offers hope for those with...
shambles profile image

Second call for participants in Graves' disease study

Thyroid UK has been approached again about a clinical trial investigating a new drug for Graves’...
lynmynott profile image
Partner

A new T3 derivative shows promise in treatment with T3 and smaller FT3 spikes after taking it

Ths paper and abstract is downloadable. It demonstrates that the new T3 derivative has a good...
diogenes profile image
Remembering

Antithyroid Treatment as Effective as RAI for Graves Relapse and better for TED

Low-dose antithyroid drug therapy for Graves' disease relapse is as effective as radioiodine (RAI)...
Clutter profile image

Moderation team

See all
RedApple profile image
RedAppleAdministrator
SlowDragon profile image
SlowDragonAdministrator
Jaydee1507 profile image
Jaydee1507Administrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.